Showing results (51-60 of 74) with videos related to
Sort By:
Pageof 8
Scandinavian Journal of Infectious Diseases|August 16, 2005
Prevention of viral hepatitis in the Nordic countries and GermanyDavid Fitzsimons, Guido François, Katharina Alpers, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2021
Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus VaccinationJohn Tyler Sandberg, Sebastian Ols, Marie Löfling, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 12, 2020
Magnitude and Functional Profile of the Human CD4<sup>+</sup> T Cell Response throughout Primary Immunization with Tick-Borne Encephalitis Virus VaccineRenata Varnaitė, Kim Blom, Margit H Lampen, et al.Vaccine|May 4, 2010
Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 yearsHelen Marshall, Terry Nolan, Javier Díez Domingo, et al.Vaccine|October 4, 2015
Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adultsRoman Chlibek, Karlis Pauksens, Lars Rombo, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 15, 2012
A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccinesElina O Erra, Helena Hervius Askling, Lars Rombo, et al.Vaccine: X|May 15, 2024
Lot-to-lot immunogenicity consistency of the respiratory syncytial virus prefusion F protein vaccine in older adultsMurdo Ferguson, Alexander Murray, Lew Pliamm, et al.Vaccine|January 12, 2013
13-Valent pneumococcal conjugate vaccine (PCV13) in children partially immunized with 7-valent pneumococcal conjugate vaccine (PCV7): a phase 3, open-label trialSven Arne Silfverdal, Carl-Erik Flodmark, Lars Rombo, et al.Malaria Journal|December 22, 2011
Plasmodium falciparum population dynamics during the early phase of anti-malarial drug treatment in Tanzanian children with acute uncomplicated malariaAnja M Carlsson, Billy E Ngasala, Sabina Dahlström, et al.The Journal of Infectious Diseases|June 6, 2020
Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine: Persistence and Anamnestic Response to Additional Doses Administered 10 Years After Primary VaccinationAndrew Hastie, Grégory Catteau, Adaora Enemuo, et al.Pageof 8